TrendsWide
Contact US
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
No Result
View All Result
Home News

Hope for women with the ‘Angelina Jolie’ gene

by souhaib
June 17, 2021
in News
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT


Actress Angelina Jolie had a preventative mastectomy in 2013 after testing positive for the mutated BRCA1 gene

There is hope for people with the ‘Jolie gene’ for cancer, from drugs which kill tumour cells while leaving healthy ones unharmed.

Around one in 200 people in the UK carry a mutation in the BRCA1 or BRCA2 genes, so have a higher risk of breast, ovarian, prostate and pancreatic cancer.

Actress Angelina Jolie had a preventative mastectomy in 2013 after testing positive for the mutated BRCA1 gene.

Now scientists have discovered a class of drugs which can destroy this type of cancer, and are set to be tested in clinical trials on patients at the end of this year.

The drugs are so badly needed because people with cancer caused by a BRCA mutation currently have only two main options for treatment.

These are chemotherapy and drugs called PARP inhibitors, which are only currently routinely available for those with ovarian cancer and do not work for everybody.

Where PARP inhibitors fail in people whose cancer had spread, the new drugs could provide a lifeline treatment.

Called POLQ inhibitors, they prevent cancer cells repairing themselves, while having no effect on healthy cells.

They have been found to destroy tumour cells taken from patients with breast, ovarian, prostate and pancreatic cancer, and the next step is proving they work within the body when taken as a pill.

Chris Lord, professor of cancer genomics at the Institute of Cancer Research in London, who co-led a study on the drugs, said: ‘A significant number of patients are given PARP inhibitors like the drug Olaparib for ovarian cancer and after a while they stop working.

‘The drugs we have identified could provide a much-needed new way to treat people with hereditary cancer, including those where PARP inhibitors have failed.’

Cancer linked to the BRCA genes runs within families, with Angelina Jolie’s mother having died from ovarian cancer at the age of 56.

People with faulty versions of the BRCA genes are at greater risk of cancer because they cannot repair damaged DNA in their cells.

What is the BRCA gene and how does it affect people’s risk of cancer?

Having a mutated BRCA gene – as famously carried by Angelina Jolie – dramatically increases the chance a woman will develop breast cancer in her lifetime, from 12 per cent to 90 per cent. 

Between one in 800 and one in 1,000 women carry a BRCA gene mutation, which increases the chances of breast and ovarian cancer. 

Both BRCA1 and BRCA2 are genes that produce proteins to suppress tumours. When these are mutated, DNA damage can be caused and cells are more likely to become cancerous.  

The mutations are usually inherited and increase the risk of ovarian cancer and breast cancer significantly.    

When a child has a parent who carries a mutation in one of these genes they have a 50 percent chance of inheriting the mutations.  

About 1.3 per cent of women in the general population will develop ovarian cancer, this increase to 44 percent of women who inherit a harmful BRCA1 mutation. 

It means they can develop abnormal cells, which grow rapidly to become tumours.

But the benefit of the BRCA fault is that it prevents cancerous cells, as well as healthy ones, from repairing themselves.

Happily, POLQ inhibitors do the same thing, leaving cancer cells no way to fix themselves so that they die.

Healthy cells, which still contain a normal copy of the BRCA gene, can repair their damage normally, so survive.

This avoids a major pitfall of chemotherapy, where both cancer cells and healthy cells are killed, causing side effects such as sickness and hair loss.

A major reason for new treatments being needed is that it is all too common for women with ovarian cancer which has spread to find the current drugs, PARP inhibitors, no longer work after a while.

But POLQ inhibitors could provide another line of defence, with both sets of drugs killing cancer cells by stopping them repairing their DNA, but POLQ inhibitors doing it slightly differently.

Mini-tumours grown in the lab which had mutated so that PARP inhibitors no longer worked on them were killed easily by POLQ inhibitors, according to the study published in the journal Nature Communications.

That suggests both drugs could be used together in the future as a super-treatment.

Clinical trials, led by pharmaceutical company Artios are due to start in the last three months of the year.

Michelle Mitchell, chief executive at Cancer Research UK, said: ‘We are always trying to find newer and better ways to outstep cancer, especially when it stops responding to current treatments.

‘By revisiting weaknesses in the BRCA repair pathway, researchers have not only found a way to make PARP inhibitors more effective, but they may have also identified an entirely new class of targeted drugs for BRCA cancers, which could include pancreatic cancer which has limited treated options.

‘We look forward to seeing if these promising results in the lab transfer into benefits for patients when tested in trials.’ 



Source link

You might also like

How to pick the right interior design course for your needs?

England v India: Sophia Dunkley will remember Test debut ‘for a long time’

Belgium’s ‘X factor’ proves the difference as Kevin de Bruyne shines

Share this:

  • Twitter
  • Facebook
  • More
  • Pinterest
  • Telegram
  • Email
Tags: bbc healthdailymail heath
Share30Tweet19
Previous Post

Belgian manhunt for armed far-right suspect enters second month

Next Post

Who will win the College World Series? Eight-team field packed with MLB-level talent and big bashers

souhaib

Recommended For You

How to pick the right interior design course for your needs?

by souhaib
July 12, 2022
0

Choosing to study interior design can be a daunting task. There are many schools and programs out there that all offer different things. How do you know which...

Read more

England v India: Sophia Dunkley will remember Test debut ‘for a long time’

by souhaib
June 18, 2021
0

As Sophia Dunkley raised her bat to celebrate reaching a half-century on Test debut against India, her mum was one of the many spectators applauding.So too were her...

Read more

Belgium’s ‘X factor’ proves the difference as Kevin de Bruyne shines

by souhaib
June 18, 2021
0

Belgium needed their 'X factor' substitutions to save them against Denmark and book their place in the last 16 of Euro 2020 after being "put to the test"...

Read more

Why US millennials are quitting big cities

by souhaib
June 18, 2021
0

Smaller cities around the US are offering incentives, sometimes up to $15,000, for young talent to move there. And with remote work on the rise, people are freer...

Read more

Once the future, US now captive to its past

by souhaib
June 18, 2021
0

At the top of Wall Street is the cemetery of Trinity Church, where one of the most storied founding fathers, Alexander Hamilton, is interred. Then I turn right...

Read more
Next Post

Who will win the College World Series? Eight-team field packed with MLB-level talent and big bashers

No Result
View All Result

Recent Posts

  • the big top
  • 7 Proven Techniques to Lower Risks for Your Dropshipping Retail outlet
  • Stocks, US Futures Slip as Important Inflation Data Loom: Markets Wrap
  • Fitness Unbranded – Unbranded Content For Fitness Pros Reviews 2022
  • Argentina specifies voluntary debt swap in the domestic market

Browse by Category

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Categories

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Pages

  • Contact US
  • Newsletter
  • Privacy Policy
  • Terms & Conditions

© 2021 - TrendsWide

No Result
View All Result
  • Home
  • Contact US
  • Privacy Policy
  • Trending
  • U.S.
  • Economie
  • Deals
  • Reviews
  • Cryptocurrency
  • Health
  • Life Style
  • NBA

© 2021 - TrendsWide